<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:"Trebuchet MS";
panose-1:2 11 6 3 2 2 2 2 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";
mso-fareast-language:EN-US;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri","sans-serif";
mso-fareast-language:EN-US;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:70.85pt 70.85pt 70.85pt 70.85pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=NL-BE link=blue vlink=purple><div class=WordSection1><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=516 style='width:387.0pt'><tr><td style='padding:0cm 0cm 0cm 0cm'><p class=MsoNormal><span lang=EN-US style='font-size:18.0pt;font-family:"Trebuchet MS","sans-serif";mso-fareast-language:NL-BE'>REVOLUTIONIZING NEXT-GENERATION <br>SEQUENCING:<br>Tools and Technologies<o:p></o:p></span></p><p class=MsoNormal><i><span style='font-size:9.0pt;font-family:"Trebuchet MS","sans-serif";mso-fareast-language:NL-BE'>15-16 JANUARY 2015 // LEUVEN, BELGIUM<o:p></o:p></span></i></p></td></tr><tr style='height:22.5pt'><td style='padding:0cm 0cm 0cm 0cm;height:22.5pt'><p class=MsoNormal><span style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-language:NL-BE'> <o:p></o:p></span></p></td></tr><tr><td style='padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='margin-bottom:9.0pt;line-height:12.0pt'><span lang=EN-US style='font-size:9.0pt;font-family:"Trebuchet MS","sans-serif";color:#58676D;mso-fareast-language:NL-BE'>We would like to invite you to ‘Revolutionizing Next-Generation Sequencing: Tools and Technologies’, a VIB conference taking place in the heart of Europe (Leuven, Belgium) from 15-16 January, 2015.<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:9.0pt;line-height:12.0pt'><span lang=EN-US style='font-size:9.0pt;font-family:"Trebuchet MS","sans-serif";color:#58676D;mso-fareast-language:NL-BE'>The meeting features several top scientists in the field, as well as many speakers from top management scientists of companies advancing the state of the art in NGS. The meeting will include sessions on Population Sequencing, Sample Prep, Next-Gen Platforms, Single-Cell Genomics, Epigenomics, Next-Gen Transcriptomics, Ultra-long reads and Assembly, and Bioinformatics.<br>Join us for great talks and networking with colleagues in the field; our meeting has already attracted more than 250 participants !<br><br><br><b>SPEAKERS</b><br><br><i>Academic </i><br>Jan Korbel (EMBL), Xu Xun (BGI), Eske Willerslev (Centre for GeoGenetics), David Jaffe (Broad Institute), Mark Akeson (UCSC), Evan Eichler (University of Washington), Fuchou Tang (Peking University), Mats Nilsson (SciLifeLab), Ido Amit (Weizmann Institute), Ryan Lister (University of Western Australia), Jin Billy Li (Stanford University), James Eberwine (University of Pennsylvania), Patrick Stahl (SciLifeLab and Karolinska Institute), Nick Loman (University of Birmingham), James Taylor (Johns Hopkins University), Peter Van Loo (Cancer Research UK)<br><br><i>Industry</i><br>Alex Dickinson (<i>Illumina</i>), Radoje Drmanac <i>(Complete Genomics)</i>, Mike Lelivelt <i>(Thermo Fisher/Life Technologies), </i>Marie Mikkelsen (<i>Samplix</i>), Jeremy Gillespie (<i>Enzymatics</i>), Max Van Min <i>(Cergentis)</i>, Gordon Hamilton <i>(Picoseq)</i>, Johnsee Lee <i>(Personal Genomics)</i>, Paul Schaffer <i>(Roche)</i>, David Johnson <i>(Gigagen)</i>, Jay West <i>(Fluidigm)</i>, Tobias Ost <i>(Cambridge Epigenetix)</i>, Sharon Squazzo <i>(Diagenode)</i>, Annabelle Gerard <i>(HiFiBio)</i>, Alexander Seitz <i>(Lexogen)</i>, Gary Schroth <i>(Illumina)</i>, Mikael Samuelsson <i>(Spatial Transcriptomics)</i>, Ralph Vogelsang <i>(Pacific Biosciences)</i>, Han Cao <i>(BioNano Genomics)</i>, John Oliver <i>(Nabsys)</i>, Mike Furness <i>(DNAnexus)</i>, Hans Karten <i>(Genalice)</i>, Roald Forsberg <i>(CLC Bio-Qiagen)</i>, Pieter van Rooyen <i>(Edico Genome)</i><br><br><br><b>MEMBERS OF THE ORGANIZING COMMITTEE</b><br><br>Mark Veugelers, VIB Headquarters, Gent<br>Peter Verhasselt, VIB Nucleomics Core Facility, Leuven<br>Albena Jordanova, VIB Department of Molecular Genetics, University of Antwerp<br>Halina Novak, VIB Headquarters, Gent<br>Evy Vierstraete, VIB Headquarters, Gent<o:p></o:p></span></p></td></tr><tr><td style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left><tr style='height:74.25pt'><td width=373 style='width:279.75pt;padding:0cm 0cm 0cm 0cm;height:74.25pt'><p class=MsoNormal><span style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-language:NL-BE'><img width=373 height=54 id="Picture_x0020_3" src="cid:image001.jpg@01D012FA.CF964480" alt="Description: https://i2.createsend1.com/ei/r/EF/6B2/28E/csimport/Date.133600.jpg"></span><span style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-language:NL-BE'><o:p></o:p></span></p></td><td width=142 style='width:106.5pt;padding:0cm 0cm 0cm 0cm;height:74.25pt'><p class=MsoNormal align=right style='text-align:right'><a href="http://vib.createsend1.com/t/r-l-mhlkdll-l-d/"><span style='font-size:12.0pt;font-family:"Times New Roman","serif";color:#58676D;mso-fareast-language:NL-BE;text-decoration:none'><img border=0 width=142 height=54 id="Picture_x0020_2" src="cid:image002.jpg@01D012FA.CF964480" alt="Description: https://i7.createsend1.com/ti/r/55/64A/B39/205136/images/register.jpg"></span></a><span style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-language:NL-BE'><o:p></o:p></span></p></td></tr></table></td></tr></table></div><p class=MsoNormal><o:p> </o:p></p></div></body></html>